Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells. (Q39827973)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

Christian P. Pallasch

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

U Kruse

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

M Bantscheff

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

D Eberhard

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

L Frenzel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

S Ghidelli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

S K Maier

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

T Werner

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

C M Wendtner

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

14 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

89-100

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Translation of the Philadelphia chromosome into therapy for CML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Kinase drug discovery approaches in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Targeting cancer with small molecule kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Advances in chemotherapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Novel molecular diagnostic and therapeutic targets in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Quantitative phosphoproteomics by mass spectrometry: past, present, and future

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Proteomics strategy for quantitative protein interaction profiling in cell extracts.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Chemical proteomics identifies unanticipated targets of clinical kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Can we rationally design promiscuous drugs?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Robust and sensitive iTRAQ quantification on an LTQ Orbitrap mass spectrometer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

A quantitative analysis of kinase inhibitor selectivity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Features of selective kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Establishment of a novel human B-CLL-like xenograft model in nude mouse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Advancing therapy for chronic lymphocytic leukemia--the role of rituximab

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

The multi-tasking P-TEFb complex

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Large-scale mapping of human protein-protein interactions by mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

MLL translocations, histone modifications and leukaemia stem-cell development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

21 January 2018

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

7 January 2021

based on heuristic

inferred from DOI database lookup

Advancing Therapy For Chronic Lymphocytic Leukemia-the Role Of Rituximab

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.233

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2010.233

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

release_42s25ds7g5gsfna2it7ph2oilq

1 reference

https://api.fatcat.wiki/v0/release/42s25ds7g5gsfna2it7ph2oilq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20944678%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39827973&oldid=2203201404"